CLAYTON UTZ Alpharma Inc. Alpharma Oral Pharmaceuticals Acquisition Corp. PartnerCo Mayne Nickless Limited ACN 004 073 410 Mayne Mayne Health Logistics Pty Limited ACN 097 064 894 BidCo Third Variation Agreement
XXXXXXX XXX
Alpharma Inc.
Alpharma
Oral Pharmaceuticals Acquisition Corp.
PartnerCo
Mayne Xxxxxxxx Limited ACN 004 073 410
Mayne
Mayne Health Logistics Pty Limited ACN 097 064 894
BidCo
Table of Contents
1. Definitions and interpretation *
1.1 Definitions *
1.2 Interpretation *
2. Offer Extension *
Third Variation Agreement made at on September 17, 2001
Parties Alpharma Inc. of Xxx Xxxxxxxxx Xxxxx, Xxxx Xxx, Xxx Xxxxxx, Xxxxxx Xxxxxx of America, 07024 ("Alpharma")
Oral Pharmaceuticals Acquisition Corp. of Xxx Xxxxxxxxx Xxxxx, Xxxx Xxx, Xxx Xxxxxx, Xxxxxx Xxxxxx of America, 07024 ("PartnerCo")
Mayne Xxxxxxxx Limited ACN 004 073 410 of Xxxxx 00, 000 Xx Xxxxx Xxxx, Xxxxxxxxx, Xxxxxxxx, Xxxxxxxxx ("Mayne")
Mayne Health Logistics Pty Limited ACN 097 064 894 of Xxxxx 00, 000 Xx Xxxxx Xxxx, Xxxxxxxxx, Xxxxxxxx, Xxxxxxxxx ("BidCo")
Recitals
- The parties to this Third Variation Agreement agree to vary the Put and Call Agreement in accordance with the terms of this agreement.
The parties agree
- Definitions and interpretation
- Definitions
- Interpretation
- Offer Extension
In this agreement:
"Put and Call Agreement" means the put and call option agreement entered into on 12 July 2001 by Alpharma, PartnerCo, Mayne and BidCo under which PartnerCo grants to Mayne a put option over shares in BidCo and BidCo grants to PartnerCo a call option to purchase shares in Faulding Holdings, Inc. and its subsidiaries and certain other oral pharmaceutical assets owned by XX Xxxxxxxx & Co Limited and its subsidiaries on the terms and conditions therein appearing (as amended by variation agreements dated 17 August and 30 August 2001).
"Third Variation Agreement" means this agreement.
In this agreement terms used have the meaning given to them in the Put and Call Agreement, unless otherwise defined.
Clause 2.4(a)(ii) of the Put and Call Agreement is amended by restating subclause (B) in its entirety to read "28 September 2001" and Alpharma and PartnerCo consent to the extension of the Offer Period to 28 September 2001 made by BidCo on 13 September 2001.
Signed as an agreement.
Executed by Alpharma Inc. by
|
Name: Xxxxxx X. Xxxxxx Title: Vice President and Chief Legal Officer |
Executed by Oral Pharmaceuticals Acquisition Corp. by
|
Name: Xxxxxx X. Xxxxxx Title: Secretary |
Executed by Mayne Xxxxxxxx Limited ACN 004 073 410 by or in the presence of:
|
|||
|
|
||
|
|
Executed by Mayne Health Logistics Pty Limited ACN 097 064 894 by or in the presence of:
|
|||
|
|
||
|
|